BR112014015605A2 - método de reconstituição para formulações de proteína seca de alta concentração - Google Patents
método de reconstituição para formulações de proteína seca de alta concentraçãoInfo
- Publication number
- BR112014015605A2 BR112014015605A2 BR112014015605A BR112014015605A BR112014015605A2 BR 112014015605 A2 BR112014015605 A2 BR 112014015605A2 BR 112014015605 A BR112014015605 A BR 112014015605A BR 112014015605 A BR112014015605 A BR 112014015605A BR 112014015605 A2 BR112014015605 A2 BR 112014015605A2
- Authority
- BR
- Brazil
- Prior art keywords
- high concentration
- dry protein
- protein formulations
- formulations
- reconstitution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Degasification And Air Bubble Elimination (AREA)
- Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
Abstract
resumo "método de reconstituição para formulações de proteína seca de alta concentração" a presente invenção refere-se ao fornecimento de um novo método para a reconstituição de formulações secas que compreendem biomoléculas e, em particular, a formulações de proteína seca, e a produtos farmacêuticos ou veterinários adequados para a administração parenteral contendo formulações reconstituídas preparadas de acordo com o novo método da invenção.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1122430.0A GB201122430D0 (en) | 2011-12-23 | 2011-12-23 | Reconstitution method for high concentration dry protein formulation |
PCT/GB2012/053266 WO2013093525A1 (en) | 2011-12-23 | 2012-12-24 | Reconstitution method for high concentration dry protein formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014015605A2 true BR112014015605A2 (pt) | 2017-07-04 |
Family
ID=45695059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014015605A BR112014015605A2 (pt) | 2011-12-23 | 2012-12-24 | método de reconstituição para formulações de proteína seca de alta concentração |
Country Status (8)
Country | Link |
---|---|
US (1) | US20140308293A1 (pt) |
EP (1) | EP2793852A1 (pt) |
JP (1) | JP2015511129A (pt) |
BR (1) | BR112014015605A2 (pt) |
CA (1) | CA2859287A1 (pt) |
GB (1) | GB201122430D0 (pt) |
IN (1) | IN2014MN01381A (pt) |
WO (1) | WO2013093525A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201313368D0 (en) | 2013-07-26 | 2013-09-11 | Xstalbio Ltd | Novel Reconstitution devices |
WO2016036807A1 (en) * | 2014-09-03 | 2016-03-10 | Entegrion, Inc. | Acceleration of reconstitution of plasma powder by mixing with small beads |
US10143625B2 (en) | 2015-03-17 | 2018-12-04 | Recon Therapeutics, Inc. | Pharmaceutical reconstitution |
SG11201901081XA (en) | 2016-08-17 | 2019-03-28 | Boehringer Ingelheim Int | Process for the preparation of highly concentrated liquid formulations containing biomolecules |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178884A (en) * | 1988-05-18 | 1993-01-12 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell compositions |
DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
DE10211227A1 (de) * | 2002-03-13 | 2003-10-02 | Aventis Behring Gmbh | Verfahren zur Rekonstitution von Iyophilisierten Proteinen |
AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
EP1958618A1 (de) * | 2007-02-15 | 2008-08-20 | Octapharma AG | Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren |
WO2011017070A1 (en) | 2009-07-28 | 2011-02-10 | Merck Sharp & Dohme Corp. | Methods for producing high concentration lyophilized pharmaceutical formulations |
-
2011
- 2011-12-23 GB GBGB1122430.0A patent/GB201122430D0/en not_active Ceased
-
2012
- 2012-12-24 IN IN1381MUN2014 patent/IN2014MN01381A/en unknown
- 2012-12-24 CA CA2859287A patent/CA2859287A1/en not_active Abandoned
- 2012-12-24 US US14/367,715 patent/US20140308293A1/en not_active Abandoned
- 2012-12-24 BR BR112014015605A patent/BR112014015605A2/pt not_active IP Right Cessation
- 2012-12-24 EP EP12813947.4A patent/EP2793852A1/en not_active Withdrawn
- 2012-12-24 WO PCT/GB2012/053266 patent/WO2013093525A1/en active Application Filing
- 2012-12-24 JP JP2014548210A patent/JP2015511129A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2793852A1 (en) | 2014-10-29 |
US20140308293A1 (en) | 2014-10-16 |
WO2013093525A1 (en) | 2013-06-27 |
JP2015511129A (ja) | 2015-04-16 |
IN2014MN01381A (pt) | 2015-04-17 |
GB201122430D0 (en) | 2012-02-08 |
CA2859287A1 (en) | 2013-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012033214A2 (pt) | método e composições para distribuição no snc de iduronato-2-sulfatase | |
BR112015008186A2 (pt) | formulação de um anticorpo estável e de baixa viscosidade | |
MX357393B (es) | Formulaciones estabilizadas que contienen anticuerpos anti - ang2. | |
MX352823B (es) | Formulaciones de proteinas que contienen aminoacidos. | |
AU2016204371A1 (en) | Lyophilised and aqueous anti-CD40 antibody formulations | |
CY1116311T1 (el) | Συνθεσεις ινσουλινων υπερ-ταχειας δρασης | |
BR112016002614B8 (pt) | Imunocitoquina e composição farmacêutica | |
BRPI1012141A2 (pt) | conjugado de sirna e método de preparação do mesmo | |
BR112012033197A2 (pt) | métodos e composições para liberação de cns de n-sulfatase de heparano. | |
AR093377A1 (es) | Anticuerpos anti-notch y conjugados de anticuerpo-farmaco | |
BR112013031021A2 (pt) | composições e métodos para a inibição da expressão de gene do vírus da hepatite b' | |
BR112012029280A2 (pt) | variante de domínio variável único de imunoglobulina antialbumina sérica, imunoglobulina anti-sa, ligando multiespecífico, proteína de fusão, composição, ácido nucleico, vetor, célula hospedeira isolada, e, uso de uma variante, ligando multiespecífico ou proteína de fusão | |
BR112014027584A2 (pt) | compostos e composições para inibir a atividade de abl1, abl2 e bcr-abl1 | |
WO2014004993A3 (en) | Methods of reducing ldl-p | |
BR112013027963A2 (pt) | "variante de subtilisina com atividade proteolítica, ácido nucleico, vetor de expressão, célula hospedeira, composição e método de limpeza". | |
BR112012015721A2 (pt) | modificação covalente de proteínas dirigida por ligante | |
BR112013019975A2 (pt) | proteínas de ligação de antígeno, composição farmacêutica, uso de uma proteína de ligação de antígeno, método para o tratamento de um paciente e método para a preparação de uma proteína de ligação de antígeno, ácido nucleico, vetor e célula hospedeira" | |
EA201791850A1 (ru) | Борсодержащие малые молекулы | |
EA200870264A1 (ru) | Композиция антител | |
BR112016008576A2 (pt) | Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária | |
BR112014028997A2 (pt) | formulações estabilizadas contendo anticorpos anti-dll4 | |
BR112015004467A2 (pt) | método para controlar a heterogeneidade de proteínas | |
BR112014010222A8 (pt) | formulação de enzima líquida e processo para sua preparação | |
BR112014031841A2 (pt) | formulação farmacêutica | |
AR077384A1 (es) | Una formulacion farmaceutica inyectable de melfalano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |